SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to a massive volume spike and price surge, triggering multiple trading halts, as community discussion focuses on its extremely low float and high insider ownership for a potential short squeeze. Many are comparing it to recent explosive SPACs, with speculative targets suggesting significant upside, fueled by talking points like a rumored "sex toy manufacturer" acquisition. The stock's momentum reflects its position as a key play in the current "SPAC mania" for micro-float tickers.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is rapidly trending due to a potent combination of its extremely low share float and a potential short squeeze, driving significant momentum. The recent announcement of a strategic manufacturing partnership, expected to boost production margins, further amplifies investor interest. The community is actively discussing strong buying defense and a "textbook" short squeeze play as the company continues to expand global adoption of its fingerprint drug screening technology.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings (ONDS) is trending due to recent autonomous system orders and the FCC's ban on foreign-made drones, which significantly boosts its role in the domestic market. The community is actively discussing a potential short squeeze and anticipating a significant price breakout, with many seeing dips as buying opportunities. This positions Ondas as a crucial player in the growing defense and critical infrastructure sectors for autonomous and counter-drone solutions.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after the FDA issued a Complete Response Letter for its relacorilant hypertension indication, triggering a sharp stock decline and intense community debate. Investors are divided, with many viewing the sell-off as an overreaction given the company's existing profitable drug and other pipeline programs, while others express caution regarding potential delays and future prospects.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending following its recent FDA approval of NEREUS, the first new motion sickness treatment in over four decades, validating a significant pipeline asset. Community discussion highlights the drug's broader potential for GLP-1 induced nausea, fueling speculation of substantial upside, a potential short squeeze, and even a buyout, given the company's strong financial standing and additional upcoming regulatory catalysts.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following its CEO's strategic insights on CNBC and news of spinning off its cloud business into ChronoScale, a move seen by many as unlocking significant value and clarifying its pure-play AI data center infrastructure focus. The community is actively discussing sustained demand from hyperscalers and strong analyst confidence ahead of its upcoming earnings report, fueling bullish sentiment despite recent price volatility. This strategic realignment aims to capitalize on the booming AI infrastructure market with a clearer business model and substantial contracted revenue.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst a wave of strong bearish sentiment, largely attributed to sustained selling pressure, high short interest, and year-end tax loss harvesting. The community is actively discussing the recent FDA approval of Novo Nordisk's oral Wegovy pill, seeing a potential for partnership and a significant catalyst for HIMS's future growth in GLP-1 offerings, alongside its ongoing expansion in D2C lab testing and international markets. Despite current frustration, many long-term investors are using this dip as a buying opportunity, anticipating a strong reversal.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after rival Corcept Therapeutics received an FDA Complete Response Letter for its Cushing's syndrome drug, effectively removing a near-term competitor for Xeris's Recorlev. The community is buzzing with bullish sentiment, emphasizing Recorlev's blockbuster potential and the significant undervaluation of XERS, further supported by advancing pipeline assets like XP-8121 and robust gross margins.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA's acceptance and priority review of its supplemental New Drug Application for AXS-05 in Alzheimer's disease agitation, with an action date anticipated in the near future. This significant regulatory milestone, combined with growing sales of its existing CNS therapies like Auvelity, has ignited immense optimism within the community, with many anticipating substantial long-term value and discussing breakthrough potential.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

Motorola Solutions ($MSI) is trending following strategic acquisitions in advanced communications and AI-powered video monitoring, reinforcing its leadership in mission-critical technology for public safety and enterprise security. Community sentiment reflects a strong focus on institutional accumulation, evident in large dark pool trades and technical indicators suggesting the stock is oversold, signaling potential for a reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best-Performing Country ETFs of 2025

EWY, GREK, EZA, EWP and EPOL surged in 2025 as international ETFs beat U.S. peers, due to cheaper valuations, policy stimulus and diversified market exposure.

 The Google, Apple, Meta, Amazon, and Microsoft logos appear on a smartphone screen in this illustration photo in Reno, United States, on December 30, 2024.

As 2025 Bids Adieu, A Look At How Mag 7 Stocks Are Positioned On Charts

Six of the “Magnificent 7” stocks are trading above their 200-DMA, with the notable exception of Meta Platforms.

Equity

Top-Performing International ETFs of 2025

International ETFs like VEA, EZU & EEM outshone U.S. peers in 2025 as cheaper valuations, diversified exposure, and stimulus measures drove substantial gains.

Will Santa Claus Rally Set In for 2025? 4 Best ETF Areas to Explore

Santa Rally may lift Wall Street! ETFs like MAGS, XME, JETS & ITA could benefit in Dec -- Jan amid seasonal optimism and market tailwinds.

6 Top-Performing ETF Areas of Last Week 

Cannabis, metals, space and health care led ETF gains last week. WEED, CNBS, SIL, UFO, GDXJ, PLTM and OZEM outperformed despite tech weakness.

5 Best-Performing Leveraged ETFs of Last Week

Cannabis, space, nat gas & auto led last week's leveraged ETF winners. MSOX, RKLX, KOLD, VOYX and CVNX posted outsized gains despite tech weakness.

<ul class="summary-bullets"><li>Jensen Huang’s pitch to President Donald Trump centered on keeping Chinese developers tied to U.S. technology.</li><li>He reportedly said that long-term U.S. leadership in AI depends on ensuring that global developers continue to build on American platforms.</li><li>The export approval of Nvidia’s H200 chips has reportedly prompted Chinese government officials to hold emergency meetings with local tech giants like Alibaba.</li></ul>Nvidia CEO Jensen Huang reportedly&nbsp;spoke to President Donald Trump on the strategic importance of ensuring Chinese developers use American technology rather than China’s own tech stack&nbsp;to convince him to approve the export of Nvidia’s H200 chips to China.U.S. Commerce Secretary Howard Lutnick&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/live-tv/">told</a> CNBC on Thursday that the two discussed the deal at least a dozen times before it was finalized. He explained that Huang’s central argument was around long-term U.S. advantage in artificial intelligence.&nbsp;<blockquote>“They talked about it a lot. More than a dozen times.”Howard Lutnick, U.S. Secretary of Commerce</blockquote><a href="https://stocktwits.com/symbol/NVDA">Nvidia’s stock</a> fell as much as 1.4% in pre-market trading. On Stocktwits, retail sentiment around the AI bellwether trended in ‘bearish’ territory over the past day.<h2 class="st-heading-2">Keeping Talent on American Platforms</h2>The CEO reportedly told Trump that if Chinese developers become accustomed to domestic technology, they would gain expertise that could eventually challenge U.S. leadership. By contrast, requiring them to work on American systems would maintain leverage, ensuring that Chinese developers remain partially dependent on U.S. innovations.China, on the other hand, has&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-h200-export-prompts-emergency-meeting-with-alibaba-bytedance-tencent/cLIHRApRENU">reportedly</a> been holding emergency meetings with local tech giants like Tencent (TCEHY), ByteDance (BYTEDANCE), and Alibaba (BABA) to ascertain their demand for Nvidia’s H200 chips after the approval came in on Monday. Government officials will decide on how many chips, if any, to import once those numbers come in.&nbsp;A Financial Times report&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/china-to-reportedly-restrict-nvidia-h200-chip-use/cLIruVQREZO">said</a> Beijing still plans to restrict access to H200 chips even after the U.S. greenlight, signaling an effort to reduce domestic reliance on American GPUs.<h2 class="st-heading-2">Export Approval Comes With Fees, Limits</h2>Trump announced Monday that H200 exports would be permitted, subject to a 25% sales fee. The H200 is described as the “second-best” Nvidia chip permitted for shipment to China under U.S. rules. Blackwell-class B300 parts remain barred.The export approval followed months of debate between the two governments amid escalating competition over AI supply chains and the strategic role of Nvidia hardware in global development.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/paypal-faces-wall-street-pessimism-over-q4-slump-bofa-downgrades-stock/cLIxOKqREnX">PayPal Faces Growing Wall Street Pessimism Over Q4 Growth Slump – BofA Latest To Downgrade Stock</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

U.S. President Donald Trump (L) invites Nvidia CEO Jensen Huang to speak in the Cross Hall of the White House during an event on "Investing in America" on April 30, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

Nvidia CEO Reportedly Spoke To Trump On The Importance Of Keeping Chinese Developers On The American Tech Stack, Says Howard Lutnick

The Commerce Secretary told CNBC that the two met over a dozen times to discuss the possibly of exporting Nvidia’s H200 chips to China before making a decision.

<ul class="summary-bullets"><li>Microsoft has announced multi-billion dollar investments in the U.A.E., Portugal, India, and Canada.</li><li>On a YTD basis, MSFT stock has outperformed AAPL and AMZN in the ‘Mag 7’ pack.</li><li>DA Davidson’s Gil Luria was bullish, citing Microsoft’s top position in OpenAI spending as key to its growth as a hyperscaler.</li></ul>Microsoft Corp. (MSFT) stock appears set to retest&nbsp;its 200-day moving average after nudging it once in late November, as the stock has faced resistance near the $492 mark in the last few weeks.<figure class="image"><img style="aspect-ratio:1311/861;" src="https://news.stocktwits-cdn.com/MSFT_png_8b3de6a9f6.webp" alt="MSFT.png" width="1311" height="861"><figcaption>MSFT's 200-DMA on Dec. 11, 2025 | Source: TradingView</figcaption></figure>Ever since late October,&nbsp;<a href="https://stocktwits.com/symbol/MSFT">MSFT stock</a> has been in a corrective mode, dropping from its high around $553 following the first quarter earnings.Despite an upbeat revenue and earnings print, MSFT stock witnessed some pressure after finance chief Amy Hood signaled that capital spending will accelerate this fiscal year. While November’s rebound helped restore some confidence, the key question now is whether the stock can hold its support level in the coming days.<h2 class="st-heading-2">Q1 Results Show Cloud Momentum</h2>Microsoft's first-quarter results surpassed Wall Street’s expectations on both revenue and earnings, thanks to ongoing momentum in its cloud business. The company reported an earnings per share (EPS) of $3.72 on revenue of $77.7 billion, compared to $3.30 EPS and $65.6 billion last year.&nbsp;Commercial cloud revenue rose 26% to $49.1 billion, with Intelligent Cloud, including Azure, contributing $30.9 billion and beating analyst estimates.Still, costs climbed sharply, with capital expenditures surging 74% to $34.9 billion, driven largely by heavy investment in GPUs and CPUs to meet growing AI-related demand.However, JPMorgan, Citi, Wells Fargo, and Morgan Stanley raised their target prices for the stock, citing strong Azure growth and elevated booking metrics.<h2 class="st-heading-2">AI Investment Spree</h2>Microsoft announced investments totaling more than $7.9 billion in the U.A.E., including more than $5.5 billion to expand AI and cloud infrastructure. This is part of a broader $15.2 billion AI initiative in the country.Last month, the software giant announced investments of $10 billion in AI infrastructure at a data center in&nbsp; Portugal, marking one of Europe’s largest AI investment projects. The company will partner with Start Campus, Nscale, and NVIDIA to deploy 12,600 next-generation NVIDIA GPUs at the site.It is also reportedly expanding its global data-center push, including plans for an AI “super factory” comprising two-story facilities in Atlanta, and a commitment of up to $5 billion to Anthropic.Earlier this week, Microsoft announced $23 billion in new AI investments, earmarking $17.5 billion for India starting in 2026 and over C$7.5 billion ($5.42 billion) in Canada over the next two years to expand its cloud capacity.Analysts remain bullish on Microsoft’s AI strategy. DA Davidson’s Gil Luria reiterated a ‘Buy’ rating last week, noting that Microsoft’s leading position in OpenAI spending should maintain its status as the fastest-growing hyperscaler.&nbsp;<h2 class="st-heading-2">The ‘Magnificent 7’ Comparison</h2>Despite MSFT stock’s recent downturn, its year-to-date gains hold above 12%. This is almost similar to Apple’s (AAPL) 12% gains in the same period. Amazon.com Inc. (AMZN) has recorded 4% gains while Tesla (TSLA) has risen over 15%. Nvidia (NVDA) and Google-parent Alphabet Inc. (GOOG, GOOGL) have been the standout stocks this year, soaring more than 35% and 67%, respectively.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘bullish’ from ‘neutral’ a day earlier, accompanied by ‘high’ message volumes.One Stocktwits user was skeptical about the stock’s technicals.<stembedurl>https://stocktwits.com/theoptionsplug/message/638808977</stembedurl>However, another sees a potential upward trend.<stembedurl>https://stocktwits.com/Foster_Todd_29/message/638794547</stembedurl>&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/china-to-reportedly-restrict-nvidia-h200-chip-use/cLIruVQREZO">China To Reportedly Restrict Nvidia H200 Chip Use</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration the Microsoft logo is displayed on a mobile phone screen in Ankara, Turkiye on October 11, 2025.

MSFT Stock Appears Set To Retest 200-DMA – Last Time It Did, Its Rebound Didn’t Endure

Ever since late October, MSFT stock has been in a corrective mode, dropping from its high around $553 following the first quarter earnings.

<ul class="summary-bullets"><li>Meta slipped below its 200-DMA after posting its Q3 results.</li><li>META’s EPS fell to $1.05, far below the expected $6.70, due to a one-time non-cash tax charge of $15.93 billion.</li><li>Overall, the Mag 7 Q3 earnings growth was the slowest since Q1 2023, FactSet analyst John Butters said.</li></ul>As the year draws to a close and heads toward the holiday season,&nbsp;every ‘Magnificent 7’ stock is trading above its 200-day moving average (DMA), with one exception: META Platforms Inc. (META), the parent company of Facebook and Instagram.META slipped below its 200-DMA after reporting third-quarter results on October 29 and has been unable to reclaim that level since.&nbsp;<figure class="image"><img style="aspect-ratio:1302/870;" src="https://news.stocktwits-cdn.com/META_200_DMA_png_c2339e88b6.webp" alt="META 200-DMA.png" width="1302" height="870"><figcaption>META 200-DMA on Dec. 10, 2025 | Source: TradingView</figcaption></figure>The tech giant posted a 26% jump in third-quarter revenue to $51.24 billion, beating both Wall Street expectations and its own outlook. However, earnings per share came in at just $1.05, far below the expected $6.70, due to a one-time non-cash tax charge of $15.93 billion, related to U.S. President Donald Trump's ‘Big Beautiful Bill’. Without that charge, EPS would have been $7.25, the company said.Meta also raised its full-year expense forecast and increased its capital spending outlook for 2025, while guiding fourth-quarter revenue to between $56 billion and $59 billion.<h2 class="st-heading-2">The Rest Of The Pack</h2>The Magnificent Seven tech giants all reported decent quarterly performances, though with varying challenges. Apple saw solid revenue and EPS growth, fueled by iPhone sales and services, while Microsoft benefited from cloud and AI initiatives.Apple shares hit an all-time high of $288.61 last Wednesday on optimism about iPhone 17 series sales.Alphabet’s revenue surged on digital advertising and cloud growth, and Amazon posted strong sales despite margin pressures from logistics. NVIDIA capitalized on AI demand, and Tesla delivered a revenue increase, but net income fell 37%.<figure class="image"><img style="aspect-ratio:1305/829;" src="https://news.stocktwits-cdn.com/Rest_of_the_pack_png_b776d8b8b6.webp" alt="Rest of the pack.png" width="1305" height="829"><figcaption>200-DMA for MAG 7 except META | Source: TradingView</figcaption></figure><h2 class="st-heading-2">A Slowdown Looming?</h2>Overall, the Mag 7 posted third-quarter earnings growth of 18.4%, marking their slowest pace since the first quarter of 2023, according to FactSet analyst John Butters. Investor reactions were muted, as rising capital expenditures and margin pressures tempered enthusiasm.Earlier this week, Yardeni Research urged investors to scale back their exposure to the market’s powerhouse Mag 7, a notable shift after 15 years of bullishness toward mega-cap tech stocks. The firm recommended moving the group underweight, expecting the drivers of earnings growth to broaden beyond the sector.Founder Ed Yardeni cautioned that the Mag Seven’s unusually high profit margins are attracting more competitors. “We see more competitors coming for the juicy profit margins of the Magnificent 7,” he said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for Roundhill Magnificent Seven ETF (MAGS) on Stocktwits remained in the ‘bearish’ zone over the past 24 hours.At the time of writing, <a href="https://stocktwits.com/symbol/MAGS">MAGS</a> was down 0.3%, having gained around 23% so far this year.<a href="https://stocktwits.com/symbol/NVDA">NVIDIA</a> (0.2%), <a href="https://stocktwits.com/symbol/TSLA">Tesla</a> (0.3%), <a href="https://stocktwits.com/symbol/AAPL">Apple</a> (0.1%), and<a href="https://stocktwits.com/symbol/AMZN">&nbsp;Amazon</a> (0.1%) traded higher, while <a href="https://stocktwits.com/symbol/MSFT">Microsoft</a> (-1.68%), <a href="https://stocktwits.com/symbol/GOOG">Alphabet</a> (-0.6%), and<a href="https://stocktwits.com/symbol/META"> META</a> (1%) traded lower in premarket.Except for Amazon.com Inc. (AMZN), every member of the “Magnificent Seven” has gained more than 10% so far this year, with Nvidia (NVDA) up 36% and Google-parent Alphabet (GOOG) soaring 66%.See also: <a href="https://stocktwits.com/news-articles/markets/equity/mind-stock-on-track-to-break-below-200-dma-after-q3-miss-sends-shares-tumbling-nearly-25/cLIHbn7RENH">MIND Stock On Track To Break Below 200-DMA After Q3 Miss Sends Shares Tumbling Nearly 25%</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Only One Stock Among The ‘Magnificent 7’ Pack Currently Trades Below 200-DMA – No, It’s Not Apple

Every MAG 7 stock has gained this year, with NVIDIA and Alphabet surging 36% and 66%, respectively.

Senstar Technologies Corporation Announces Agreement to Acquire Blickfeld GmbH

Senstar Technologies Corporation Announces Agreement to Acquire Blickfeld GmbH Senstar Technologies Corporation Announces Agreement to Acquire Blickfeld GmbH PR Newswire OTTAWA, ON, Dec. 9, 2025...

MAGS
Roundhill Magnificent Seven ETF

Feed

News

Sentiment

Fundamentals

Info

Latest MAGS News

MAGSRoundhill Magnificent Seven ETF